News & Updates
Filter by Specialty:

Diabetes, smoking predict erectile dysfunction in men after radical prostatectomy
A recent study reports functional erection in a small proportion of men 3 months after undergoing radical prostatectomy (RP). Of these, nearly half have shown a decline in erectile function at 6 months. Of note, the presence of diabetes and a smoking history are associated with erectile dysfunction.
Diabetes, smoking predict erectile dysfunction in men after radical prostatectomy
16 Dec 2022
Oral testosterone undecanoate safe, effective in hypogonadal men
Long-term treatment with an oral testosterone undecanoate (TU) formulation improves clinical outcomes in men with hypogonadism with no serious safety concerns, a study has shown.
Oral testosterone undecanoate safe, effective in hypogonadal men
15 Dec 2022
Prostate cancer genomic study shows disparity between Chinese and Caucasians with castration-sensitive disease
A large genomic study involving 1,016 Chinese patients with prostate cancer has revealed important differences in castration-sensitive disease between Chinese and Caucasian patients, but the mutation profile of metastatic castration-resistant prostate cancer (mCRPC) is similar between the populations.
Prostate cancer genomic study shows disparity between Chinese and Caucasians with castration-sensitive disease
13 Dec 2022
MDT without ADT delays systemic therapy initiation in recurrent prostate cancer
In patients with solitary metastatic recurrences of prostate cancer, metastasis-directed therapy (MDT without androgen deprivation therapy (ADT) can lead to delayed initiation of systemic therapy, according to a study.